NOVACYT |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.656 EUR | -2.53% |
|
-15.57% | -7.99% |
| May. 30 | EARNINGS AND TRADING: TPXimpact expects growth; Novacyt loss widens | AN |
| May. 30 | Novacyt: losses widen in 2023, share price falls | CF |
Business Summary
- development of solutions and diagnostic services. The group is also developing a manufacturing activity for reagents and kits for bacterial and blood tests;
- manufacture and sale of molecular screening kits (Primerdesign): for laboratories.
Number of employees: 120
Sales per Business
| EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
|---|---|---|---|---|---|
Primer Design
93.3
%
| 105 | 93.8 % | 23 | 93.3 % | -77.99% |
IT-IS International
6.7
%
| 11 | 9.7 % | 2 | 6.7 % | -84.60% |
Intercompany Eliminations
-0.1
%
| -9 | -8.3 % | 0 | -0.1 % | -99.86% |
Sales per region
| EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
|---|---|---|---|---|---|
United Kingdom
48.1
%
| 50 | 44.6 % | 12 | 48.1 % | -76.14% |
America
21.3
%
| 11 | 9.5 % | 5 | 21.3 % | -50.39% |
Europe (Excluding United Kingdom)
18.3
%
| 38 | 33.9 % | 5 | 18.3 % | -88.06% |
Asia-Pacific
8.8
%
| 11 | 9.9 % | 2 | 8.8 % | -80.35% |
Middle East
1.8
%
| 1 | 0.7 % | 0 | 1.8 % | -47.11% |
Africa
1.7
%
| 1 | 1.3 % | 0 | 1.7 % | -71.38% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Steven Gibson
DFI | Director of Finance/CFO | 41 | 17-03-31 |
Paul Oladimeji
CTO | Chief Tech/Sci/R&D Officer | - | 16-04-30 |
Joanne Mason
CTO | Chief Tech/Sci/R&D Officer | 50 | - |
Mandy Cowling
IRC | Investor Relations Contact | - | 12-05-31 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
John Brown
BRD | Director/Board Member | 69 | 23-09-07 |
Lyn Rees
CEO | Chief Executive Officer | 51 | 23-09-07 |
| Chairman | 58 | 14-09-30 | |
| Founder | 73 | 06-07-02 | |
Juliet Thompson
BRD | Director/Board Member | 57 | 17-06-26 |
Joanne Mason
CTO | Chief Tech/Sci/R&D Officer | 50 | - |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 70,626,248 | 68,366,145 ( 96.80 %) | 16,993 ( 0.0241 %) | 96.80 % |
Company contact information
Novacyt SAS
13 Avenue Morane Saulnier
78140, Vélizy-Villacoublay
+33 1 39 46 51 04
http://www.novacyt.com
Sector
Sales per Business
Sales per region
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -7.99% | 50.21M | |
| -25.27% | 120M | |
| -12.28% | 64.19M | |
| +0.27% | 57.13M | |
| +1.20% | 53.15M |
- Stock Market
- Equities
- ALNOV Stock
- Company Novacyt
